I'm one of those disappointed with the 4C after the almost unbelievable April update. I strongly believe the company should have provided a May update on the significant drop in revenue and could have provided context around this, ie repeat orders every 3 or 4 months which provides for uneven income streams if that were to be the case. I want tranparency in reporting and not just on good news. I'm actually surprised how well the SP has held up so far, but will expect a general slide over the next few weeks. Overall I remain optimistic about the huge growth potential in ZNO, which is why I haven't sold any of my shares. That is also why I don't want any dividends any time soon because I want the company to invest in its expansion in some of the huge overseas markets it is targeting. You have to strike while the iron is hot. I was also pleasantly surprised with online sales, although that makes the drop off in revenue in May and June even more dramatic than my first glance of this report indicated. I hope that the annual report can shed more light on this.
- Forums
- ASX - By Stock
- ZNO
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-106
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZNO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
-0.002(7.41%) |
Mkt cap ! $8.885M |
Open | High | Low | Value | Volume |
2.5¢ | 2.5¢ | 2.5¢ | $5.49K | 219.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 340519 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 41763 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 340519 | 0.025 |
2 | 42208 | 0.024 |
1 | 300000 | 0.023 |
2 | 138322 | 0.022 |
1 | 23840 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 41763 | 1 |
0.028 | 297867 | 1 |
0.029 | 252612 | 1 |
0.030 | 703000 | 3 |
0.032 | 258906 | 2 |
Last trade - 11.50am 13/11/2024 (20 minute delay) ? |
Featured News
ZNO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online